Advanced Cell Technology Receives FDA Clearance to Initiate Clinical Trials
Advanced Cell Technology, Inc. (Santa Monica, CA)
announced that it received clearance from the US Food
and Drug Administration (FDA) for the company’s
Investigational New Drug application to treat dry AMD
using retinal pigment epithelial (RPE) cells derived from
human embryonic stem cells (hESCs), according to a
co...